In this informative interview with Professor Simon Holt, an esteemed breast cancer researcher, we delve into the advancements made by Exact Sciences' Oncotype DX test. By analyzing the activity of 21 genes in breast cancers, this test accurately predicts the risk of cancer recurrence and identifies patients who truly benefit from chemotherapy. With a significant reduction in unnecessary chemotherapy prescriptions, the Oncotype DX test is revolutionizing breast cancer treatment, improving patient outcomes, and sparing individuals from the grueling side effects of unnecessary treatment.
Death of a doyen British composer slippedisc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from slippedisc.com Daily Mail and Mail on Sunday newspapers.